ArticleCancer chemotherapy and pharmacology2021

A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.

Tracy Murray Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.